ArticleFrontiers in pharmacology2018
Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.
Xiaoying Hou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papercites it
ArticleFrontiers in pharmacology2018
Xiaoying Hou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.